National Academies of Sciences%2c Engineering%2c and Medicine

A Proposed Framework for Identifying Potential Biodefense Vulnerabilities Posed by Synthetic Biology: Interim Report

Blight, K.J., A.A. Kolykhalov, and C.M. Rice. 2000. Efficient initiation of HCV RNA replication in cell culture. Science 290(5498):1972-1974. Blue Ribbon Study Panel ...
Seeking Alpha

Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative

PHOENIX, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company advancing regenerative ...